Lymphocutaneous nocardiosis due to Nocardia brasiliensis.
Nocardia species are Gram-positive bacteria responsible for systemic or cutaneous infections in humans. Nocardia brasiliensis is the most common infective agent in the cutaneous form of nocardiosis. We describe a case of a previously healthy man, who presented with lymphocutaneous Nocardia brasiliensis infection, and was successfully treated with trimethoprim-sulfamethoxazole. The identification of the isolate was confirmed by nucleotide sequence analysis of the 16S rRNA gene.
Maraki
Sofia
S
Department of Clinical Bacteriology, University Hospital of Crete, Heraklion, Crete, Greece. sv9sk@danae.med.uoc.gr
Scoulica
Efstathia
E
Alpantaki
Kalliopi
K
Dialynas
Michael
M
Tselentis
Yannis
Y
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D016470:Bacteremia / Q000175:diagnosis* / Q000188:drug therapy; D001483:Base Sequence; D005500:Follow-Up Studies; D006115:Greece; D006801:Humans; D008206:Lymphatic Diseases / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D008969:Molecular Sequence Data; D009615:Nocardia / Q000187:drug effects / Q000302:isolation & purification*; D009617:Nocardia Infections / Q000175:diagnosis* / Q000188:drug therapy; D016133:Polymerase Chain Reaction; D012329:RNA, Bacterial / Q000032:analysis; D018570:Risk Assessment; D012720:Severity of Illness Index; D017192:Skin Diseases, Bacterial / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D012329:RNA, Bacterial; D015662:Trimethoprim, Sulfamethoxazole Drug Combination